Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.48 Million USD | -46.62% |
| 2022 | 8.39 Million USD | -45.49% |
| 2021 | 15.4 Million USD | 51.21% |
| 2020 | 10.19 Million USD | 88.15% |
| 2019 | 5.41 Million USD | 1344.27% |
| 2018 | 375 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | 8.01 Million USD | -4.57% |
| 2023 FY | 4.48 Million USD | -46.62% |
| 2023 Q2 | 7.47 Million USD | -6.8% |
| 2023 Q3 | 7.7 Million USD | 3.2% |
| 2023 Q4 | 4.48 Million USD | -41.85% |
| 2022 FY | 8.39 Million USD | -45.49% |
| 2022 Q4 | 8.39 Million USD | -49.56% |
| 2022 Q3 | 16.65 Million USD | -0.52% |
| 2022 Q2 | 16.74 Million USD | 3.14% |
| 2022 Q1 | 16.23 Million USD | 5.33% |
| 2021 Q2 | 13.14 Million USD | 13.79% |
| 2021 Q1 | 11.55 Million USD | 13.4% |
| 2021 FY | 15.4 Million USD | 51.21% |
| 2021 Q4 | 15.4 Million USD | 9.57% |
| 2021 Q3 | 14.06 Million USD | 6.95% |
| 2020 Q4 | 10.19 Million USD | 19.69% |
| 2020 FY | 10.19 Million USD | 88.15% |
| 2020 Q3 | 8.51 Million USD | 11.24% |
| 2020 Q2 | 7.65 Million USD | 17.16% |
| 2020 Q1 | 6.53 Million USD | 20.62% |
| 2019 Q4 | 5.41 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 5.41 Million USD | 1344.27% |
| 2018 FY | 375 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 95.968% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 33.772% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 86.134% |
| Cosmos Health Inc. | 4.78 Million USD | 6.391% |
| Dynavax Technologies Corporation | 53.29 Million USD | 91.588% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 61.509% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 95.704% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 21.828% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 21.828% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -139.778% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -453.623% |
| Alpha Teknova, Inc. | 11.59 Million USD | 61.333% |
| Bright Green Corporation | - USD | -Infinity% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 93.169% |
| Embecta Corp. | 152.1 Million USD | 97.053% |
| PainReform Ltd. | - USD | -Infinity% |
| Journey Medical Corporation | 10.2 Million USD | 56.075% |
| Procaps Group, S.A. | 96.83 Million USD | 95.37% |
| Theratechnologies Inc. | 6.06 Million USD | 26.096% |
| Harrow Health, Inc. | 10.86 Million USD | 58.747% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -64.877% |
| Biofrontera Inc. | 10.9 Million USD | 58.902% |
| DURECT Corporation | 2.21 Million USD | -102.028% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 94.209% |
| Cronos Group Inc. | 30.33 Million USD | 85.224% |
| OptiNose, Inc. | 8.05 Million USD | 44.324% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -448299900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 21.338% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 84.133% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -67.457% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 2.741% |
| Radius Health, Inc. | 278.64 Million USD | 98.391% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -34.09% |
| ProPhase Labs, Inc. | 3.84 Million USD | -16.714% |
| Phibro Animal Health Corporation | 265.91 Million USD | 98.314% |
| Procaps Group S.A. | 96.83 Million USD | 95.37% |
| Alvotech | 74.43 Million USD | 93.977% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.871% |
| Rockwell Medical, Inc. | 5.87 Million USD | 23.642% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 64.514% |
| SIGA Technologies, Inc. | 64.21 Million USD | 93.019% |
| Tilray Brands, Inc. | 252.08 Million USD | 98.222% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 88.787% |
| Shineco, Inc. | 1.58 Million USD | -182.211% |
| PetIQ, Inc. | 159.3 Million USD | 97.186% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 3034.323% |
| Incannex Healthcare Limited | -10.01 Million USD | 144.763% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 88.295% |
| Alimera Sciences, Inc. | 1.87 Million USD | -138.584% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 88.104% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -178.38% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1662.518% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 56.811% |
| Hempacco Co., Inc. | 2.54 Million USD | -76.314% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 93.977% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 90.62% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 92.998% |
| Currenc Group, Inc. | 732.91 Thousand USD | -511.67% |
| Kamada Ltd. | 87.74 Million USD | 94.891% |
| Indivior PLC | 141.79 Million USD | 96.838% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -830.392% |
| Flora Growth Corp. | 8.5 Million USD | 47.308% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1662.518% |
| Evolus, Inc. | 10.99 Million USD | 59.238% |
| HUTCHMED (China) Limited | 50.25 Million USD | 91.08% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 95.764% |
| Akanda Corp. | 1.28 Million USD | -248.358% |